VG Life Sciences Short Interest Ratio and Short Volume

Short interest is the volume of VG Life Sciences shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 15,100 shares of VGLS short. 0.00% of VG Life Sciences' shares are currently sold short. View details.

VG Life Sciences saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 15,100 shares, an increase of 15,000.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of VG Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to VG Life Sciences: Peak Pharmaceuticals, Inc. (0.00%), Tower One Wireless Corp. (0.00%), Acura Pharmaceuticals, Inc. (0.00%), BriaCell Therapeutics Corp. (0.00%), Benitec Biopharma Inc. (0.54%), Intellipharmaceutics International Inc. (0.00%), Amarantus BioScience Holdings, Inc. (0.00%), Cotinga Pharmaceuticals Inc. (0.00%), ImmunoCellular Therapeutics, Ltd. (0.00%), and Immune Pharmaceuticals, Inc. (0.00%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.18 billion), ViacomCBS Inc. ($4.71 billion), Analog Devices, Inc. ($4.45 billion), Aon Plc ($4.28 billion), Snap Inc. ($3.70 billion), Moderna, Inc. ($3.00 billion), The Clorox Company ($2.46 billion), Peloton Interactive, Inc. ($2.40 billion), The Kroger Co. ($2.38 billion), and Expedia Group, Inc. ($2.37 billion). View all of the most shorted stocks.

Short selling VGLS is an investing strategy that aims to generate trading profit from VG Life Sciences as its price is falling. To short VG Life Sciences stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that VG Life Sciences will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for VG Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VGLS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VGLS, twice per month. The most recent reporting period available is December, 31 2020.